Theranos | Investor Conference Presentation Deck

Slide schematic 3/3

disclaimer 1/1 table 1/1 title 1/1

Components 3

disclaimer data headline

Tools 1

table/data: Challenges: Hemolysis, Clotting, Altered cell morphology. Theranos Design Considerations: Capillary tubes, Shape/diameter, Anti-coagulant coating, Anti-coagulant concentration, Rapid mixing, Fill volume indic

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

diagnostic-test 80%

Maps specific technical problems to design solutions.

Find anything

This slide outlines technical mitigation strategies for blood sample collection issues.